Provided is an ophthalmic diffractive multi-focal lens with a diffractive structure including a phase profile in which a plurality of blaze shaped zones are set in a concentric circle form, wherein: at least one of the zones serves as an adjustment zone wherein an inclination direction in the phase profile is reversed with respect to that of other zones; and a light intensity level giving a peak or focal point at a position away from three focal points in a light intensity distribution of transmitted light in an optical axis direction is kept low in comparison with a phase profile without the adjustment zone.

An ophthalmic lens includes an optic comprising an anterior surface, a posterior surface, and an optical axis. At least one of the anterior surface and the posterior surface has a surface profile including a base curvature, a refractive region having the base curvature, and a diffractive region comprising a diffractive profile including a plurality of diffractive steps. At least a portion of the diffractive profile constitutes a combination of a base diffractive profile defining multiple foci for the ophthalmic lens and an achromatizing structure that reduces longitudinal chromatic aberrations.

Intraocular lenses with a base optical power and a customized add power. The add power is customized based on at least one of ocular biometry of an individual, position of the intraocular lens in the eye and a preferred reading distance.

Methods and apparatus to improve or restore vision by causing a rebooting of the visual system of an eye with modification of visual search, sampling and stimulation away from the preferred retinal locus of fixation of an eye to enhance neural integration and perception of visual information from within the field of view are described herein. Some embodiments cause transient, reversible or repeatable redirection of environmental light away from the preferred retinal locus of fixation of an eye to multiple retinal locations that are not the preferred retinal locus of fixation. Some embodiments reduce exposure of environmental light at the preferred retinal locus of fixation of an eye for a determinable interval at a determinable rate. Some embodiments cause a defocusing of environmental light at the preferred retinal locus of fixation in an eye with a visual impairment or loss.

A multifocal ophthalmic lens includes an ophthalmic lens and a diffractive element. The ophthalmic lens has a base curvature corresponding to a base power. The diffractive element produces constructive interference in at least four consecutive diffractive orders corresponding a range of vision between near and distance vision. The constructive interference produces a near focus, a distance focus corresponding to the base power of the ophthalmic lens, and an intermediate focus between the near focus and the distance focus.

Certain embodiments provide an intraocular lens (IOL) including a lens body having an anterior surface and a posterior surface, and a diffractive structure having a plurality of echelettes formed on at least one of the anterior surface or the posterior surface. A surface profile of the diffractive structure includes a base surface profile configured to diffract an incident light in one or more diffraction orders, and an achromatizing surface profile including increased step heights in the plurality of echelettes in relation to the base surface profile, and phase offsets between adjacent echelettes of the plurality of echelettes.

The object of the invention relates to an artificial ophthalmic lens (20) that contains an anterior optical surface (21) and a posterior optical surface (22), where the anterior optical surface (21) and the posterior optical surface (22) have a common optical axis (23), and at least one of the anterior optical surface (21) and the posterior optical surface (22) is a multifocal optics (24) that at least partly has a multifocal optical diffractive profile (25). A cross apodized profile part (25) is formed on the diffractive profile (25), in other words phase shifting elements (27) are provided on the diffractive profile (25) that alternately form the elements of a decreasingly apodized series (40) and an increasingly (reversed) apodized series (41) in such a way that the decreasing and increasing elements of the two series (40, 41) form envelope curves that meet at a common intersection point (45). The object of the invention also relates to a method for the production of such an artificial ophthalmic lens (20).

An ophthalmic lens includes an optic comprising an anterior surface, a posterior surface, and an optical axis. At least one of the anterior surface and the posterior surface has a surface profile including a base curvature and a plurality of morphed sinusoidal phase shift structures. The base curvature may correspond to a base optical power of the ophthalmic lens, and the morphed sinusoidal phase shift structures may be configured to extend depth of focus of the ophthalmic lens at intermediate or near viewing distances.

An ophthalmic device includes an optic including an optic axis and a haptic structure coupled with the optic. The haptic structure includes an inner ring comprising a plurality of hinges such that portions of the inner ring reside at different radii from the optic axis. The haptic structure further includes a first loop extending from the inner ring and having two points of connection to the inner ring and a second loop extending from the inner ring and having two points of connection to the inner ring. The second loop is oriented opposite the first loop.

Devices and methods for novel retinal irradiance distribution modification (IDM) to improve, stabilize or restore vision are described herein. Also encompassed herein are devices and methods to reduce vision loss from diseases, injuries and disorders that involve damaged and/or dysfunctional and/or sensorily deprived retinal cells. Conditions that may be treated using devices and methods described herein include macular degeneration, diabetic retinopathy and glaucoma. Therapy provided by retinal IDM devices and methods described herein may also be used in combination with other therapies including, but not limited to, pharmacological, retinal laser, gene and stem cell therapies.